The inoculation challenge
The inoculation challenge
The government is being scrutinised for buying a Chinese vaccine with low efficacy rates and ties to CP Group, while the most of the population is being supplied by a firm with little experience with vaccines
published :
18 Jan 2021 at 04:30
4
The cabinet approved plans to procure several million doses of Covid-19 vaccines during 2021. Apichart Jinakul
The country is eagerly awaiting the administration process in February of CoronaVac, a Covid-19 vaccine developed by a Chinese biopharmaceutical company, which recently received a hefty investment from a Thai conglomerate.
As the race to develop effective Covid-19 vaccines heats up among several pharmaceutical companies, in an effort to counter the surge of infections worldwide, the Thai government is also in a race against time to secure much-needed vaccines, hoping inoculations will provide a beacon of hope for the masses.